Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
The bill amends 46 U.S.C. 70503 to clarify controlled-substance prohibitions while on covered vessels and requires the Coast Guard to update overdose-medication policy.
It mandates naloxone (or similar) be available at all Coast Guard installations and in each operational environment, requires Coast Guard participation in a DoD tracking system (and an MOU to enable access), and directs briefings to specified Congressional committees on implementation, incidence, and use.
The Commandant must comply with privacy laws; timelines for updates and briefings are set (mostly within 1–2 years).
Focused public-health and readiness bill with limited cost and cross-cutting controversy, historically likely to clear committees and floors.
Relative to its intended legislative type, this bill functions primarily as a substantive policy change that also imposes administrative requirements and reporting obligations. It clearly prescribes several statutory amendments and directs specific actions with timelines and responsible officials, but it omits fiscal authorization and many operational specifics that are relevant given the breadth of the requirements.
Harm-reduction focus versus concerns about discipline and enforcement
Harm-reduction focus versus concerns about discipline and enforcement
Generally supportive; sees the bill as a harm-reduction and life-saving measure for service members.
Values the mandated availability of naloxone, data collection, and clear policy updates to address fentanyl risk.
Cautiously favorable: supports life-saving measures and better data, but wants clear implementation plans, funding, and privacy safeguards.
Sees merit in interagency coordination while watching cost and operational impacts.
Mixed to skeptical: acknowledges life-saving value but worries about mandates, added bureaucracy, costs, and effects on discipline.
Wants assurance this does not impede enforcement or mission readiness.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Focused public-health and readiness bill with limited cost and cross-cutting controversy, historically likely to clear committees and floors.
The bill has not accumulated any surfaced votes yet.
Harm-reduction focus versus concerns about discipline and enforcement
Focused public-health and readiness bill with limited cost and cross-cutting controversy, historically likely to clear committees and floor…
Relative to its intended legislative type, this bill functions primarily as a substantive policy change that also imposes administrative requirements and reporting obligations. It clearly prescribes several statutory am…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.